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Abstract 
Background: To evaluate dietary use of iodized 
salt as a risk factor for hyperthyroidism in people 
living in iodine deficient areas of Pakistan.  
Methods: In this  case control study, patients 
(n=150), 50 male and 100 female, aged 35-75 years, 
from Northern region of Pakistan, with goiter and 
hyperthyroidism; and healthy control group (n=100), 
32 males and 68 females aged 35-75 years from same 
region, were selected by probability convenience 
sampling. The patient and control group were 
interviewed regarding use of iodized salt. History 
and physical examination of patient group was done 
for assessment of symptoms and goiter.  Thyroid 
stimulating hormone (TSH) and free thyroxin (FT4) 
were analyzed in Patient and Control group both.  
Results: The study revealed 67% prevalence of 
goiter between 46-55 years in patient group with 
female predominance. Grade two multinodular 
goiters were followed by Solitary nodules and 
diffuse goiter in patient group. The residents of 
Azad Jammu and Kashmir region were more affected 
in patient group. Mean FT4 was 46.5+/-22 pmol/L in 
patients and 16.036+/-8 in controls. Mean TSH was 
0.099+/-0.03 and 1.44061+/-0.39 in patients and 
controls respectively. The family history for thyroid 
disease was positive in 72% of patients and 56% in 
controls. The relative risk in iodized salt exposed vs. 
non exposed individuals showed Odd ratio of 5.2.  
Conclusion: Iodized salt is a risk factor for 
development of hyperthyroidism in iodized salt 
users living in iodine deficient areas of Pakistan.   
Key Words: Iodized salt, Hyperthyroidism, 
Thyroid stimulating hormone, Free Thyroxine (FT4) 
 
Introduction 
   Iodine,a nonmetallic element, is nutritionally an 
essential element, especially for thyroid gland. In 
solutions, it is used as anti infective, in contrast media 
and in certain medicines.1-3 The Iodine Deficiency 
Disorder (IDD) is a major nutritional problem in the 
world as estimated in 1990, about 1572000000 people 
suffered from IDD  in 118 countries.4The incidence is 
high in mountainous and flood-prone areas where 
iodine deficient soils exist. Pakistan established Goiter 
Council Cell in 1986 and in 1987, Lugols iodine oil 
capsules and injections were introduced. In 1989, the 
strategy was shifted to salt iodinization.5The ratio of 
salt to iodine depends upon the average amount of salt 
consumed per capita of target population. The daily 
recommended body requirement of iodine is 150 
µg.6This amount is based on: the calculated daily 
thyroid hormone turnover in euthyroid, the iodine 
intake producing the lowest values for serum TSH and 
for serum thyroglobulin. The amount of thyroid 
hormone replacement necessary to restore 
euthyroidism to athyreotic subjects,iodine intake 
associated with the smallest thyroid volumes in 
populations and the lowest incidence of transient 
hypothyroidism in neonatal screening with blood spot 
TSH also helps in determining daily iodine 
uptake.7The appropriate fortification level is about one 
part iodine per 20000 – 40000 parts salt or 25-50 gm 
iodine per metric ton salt.5 
    It has been observed that one of the most 
undesirable effects of salt iodization is Iodine Induced 
Hyperthyroidism (IIH), which has been reported from 
many countries of the world specifically in iodine 
deficient areas.8 In Pakistan, the development of 
hyperthyroidism after iodine fortification to the table 
salt poses a great challenge. 
 
Patients and Methods 
     The study was carried out by Department of 
Physiology, Army Medical College – Rawalpindi and 
Armed Forces Institute of Pathology- Rawalpindi, in 
2007. Through non probability convenience sampling, 
a total of 250 individuals were selected, 150 cases of 
hyperthyroidism, and 100 healthy controls. The 
criteria for selection of cases included hyperthyroid 
patients who were residents of northern region of 
Pakistan, male or female, and having goiter and 
clinical symptoms of hyperthyroidism. The Control 
group was symptom free. The exclusion criteria was, 
thyroxin intake, medicine/applicants having iodine 
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(systemic medicine, skin, vaginal, dental and contrast 
media), history of renal disease, thyroid surgery and 
thyroid radiotherapy. The goiter was assessed by 
palpation method using WHO Grade system. All the 
individuals were examined by 3 independent medical 
specialists, to clinically establish hyperthyroidism and 
also to record the prominent symptoms in these 
patients. For the assessment of TSH and FT4, venous 
blood sample was drawn between 7:00 –9:00 am, after 
+/- 6 hrs fasting. The blood samples were stored at -
20OC till analysis. Chemiluminescent technique on 
fully automated 2000 Analyzer, was used to analyze 
samples.  
 
Results 
      In patient group (n=150), 67% were between 46-55 
years, with male/female ratio 1:2 (Table-1). Out of 74% 
from hilly area, 81 % were iodized salt user and 19 % 
were non user and out of 26 % from non hilly areas, 
58.9% were user and 41% were non user. In control 
group (n=100), 63 % belonged to hilly areas, with 
71.4% user and 28.5% were non user. Azad Jammu 
and Kashmir people were more affected, 61.2% (Table-
2).  Overall in patient and control  group 75.3% and 
63%,respectively, were users(Table-3). The duration of 
iodized salt intake in patients was over 2 years in 
66.6% (n=103) of patients (Table-4). Heat intolerance 
(36%0 and palpitation (36%) were commonest 
presentations (Table 5). Goiter grading exhibited 26% 
Grade one and 74% Grade two goiters in patient group 
(Table-6). Multinodular goiter (72%) was commonest 
(Table 7). The mean concentration of FT4 was 46.5 +/- 
22 pmol/L in patients and 16.036 +/- 8 pmol/L in 
control group (normal 8-24 pmol/L) (Table-8). The  
 
Table 1:Age groups and gender of Patients and 
Controls 
Age 
group 
(Years) 
Patients (n=150) Controls (n=100) 
No(%) Gender  
Male/Female 
No (%) 
 
Gender  
Male/Female 
35-45 24(16) 8/16 14(14) 5/9 
46-55 100(67) 33/67 70(70) 22/48 
56-65 23(15) 8/15 11(11) 4/7 
66-75 3(2) 1/2 5(5) 2/3 
 
TSH was 0.099 +/-0.03 and 1.44061 +/-0.39 µIU/L in 
patients and in control group respectively (normal 0.4-
4 µIU/L) (Table-8). The family history of thyroid 
diseases was positive in 72% of patients and 56 % of 
control group (Table-9).The relative risk calculated to 
compare iodized salt exposed vs. non exposed 
individuals showed Odd ratio of 5.2 {(significant >2) 
(Table-3). 
 
Table-2:Place of residence of Patients and 
Controls in hilly and non-hilly areas 
Area Patients  
(n = 150) 
Controls 
(n = 100) 
Patients  (n = 150) Controls(n = 100) 
Users of 
iodized 
salt 
Non-users 
of iodized 
salt 
Users of 
iodized 
salt 
Non-users 
of iodized 
salt 
Hilly area 
AJ&K 68 (61.2%) 40 59 9 31 9 
Murree 35 18 28 7 11 7 
Harripur 8 5 3 5 3 2 
Total 111 
(74%) 
63 
(63%) 
90 
(81.0%)) 
21 
(18.9%)) 
45 
(71.4%) 
18 
(28.5%) 
Non Hilly Area 
Peshawar 14 12 10 4 7 5 
Taxila 12 14 6 6 6 8 
Hassan 
Abdal 
13 11 7 6 6 5 
Total 39 
(26%) 
37 
(37%) 
23 
(58.9%) 
16 
(41.0%) 
19 
(51.3%)) 
18 
(48.6%) 
 
Table-3:Dietary use of iodized salt in 
Patient and Control group 
Use of iodized 
salt 
Patients 
(n=150) 
Controls 
(n=100) 
Odds 
ratio 
Users 113(75.3%) 37(37%) 
5.2 
Non users 37(24.6%) 63(63%) 
Odds ratio > 2 is significant.   
Table-4:  Duration (in years) of iodized salt 
intake in Patient group (n=150) 
Years Patients 
Frequency  (%) 
One year 3 2 
Two years 7 4.66 
More than two years 140 93..33 
  
Table-5: Frequency distribution of presenting 
complaints in Patient group (n=150) 
Presenting complaint Frequency  (%) 
Heat Intolerance 57 38 
Palpitations 54 36 
Dyspnoea 25 17 
Fatigue 7 5 
Fine Tremors 5 3 
Eye Symptoms 2 1 
 
Table-6:Grading of goitre in Patient group (n=150) 
Grade of goitre Number of Patients Percentage 
Grade zero 0 0% 
Grade one 39 26% 
Grade two 111 74% 
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Table-7: Type of goitre in Patient group (n=150) 
Type of Goitre Number of Patients Percentage 
Diffuse goitre 19 13 
Solitary nodule 23 15 
Multinodular goitre 108 72 
 
Table-8:Serum Free T4 and TSH concentration 
in Patient and Control group 
Concentration of Hormones Mean ± SD Patients Controls 
Serum Free T4  (pmol/L) 46.5±22 16.036±8 
 Serum TSH  (mIU/L) 0.099±0.03 1.44061±0.39 
Total number of patients = 150,   Total number of controls = 100 
   
Table-9: Family history of thyroid disease in 
Patient and Control group 
Family history Patients (n=150) Controls(n=100) 
Positive 108 (72%) 56 (56%) 
Negative 42 (28%) 44 (44%) 
 
Discussion 
     Iodine Deficiency Disorders (IDD) constitute major 
nutrition problem in the world.9 Iodine deficiency is 
known to exist in northern region of Pakistan 
including Azad Jamu and Kashmir. Certain 
consequences of iodine deficiency are not reversible 
once they occur, but all can be prevented by easily 
available techniques of iodine supplementation. The 
Pakistan Government in the mid 1960’s promoted the 
use of iodized salt as the cost effective way of getting 
iodine to the affected population.10 The occurrences of 
hyperthyroidism after administration of iodized salt 
has been reported by many countries.11-16 
    At the age of fifty years or older the incidence is 3.8 
times more than that occurring before, compared to 1.6 
times for persons less than 40 years old.16 In  a 
comparative study, 68 year old subjects were 
investigated and found hyperthyroid after 
implementation of iodine supplementation program.17 
    Female predominance as reported in our study, has 
also been documented in many other countries.18 The 
reason for female predominance seems genetic factors, 
since there is an increased frequency haplotypes HLA-
B8 and -DRw3 in Caucasian, HLA-Bw36 in Japanese, 
and HLA-Bw46 in Chinese patients with the disease.19  
     In present  study multinodular goitre was the most 
frequent one (72 %).Our findings regarding type of 
goiter are supported by another study in which 
hyperthyroidism was found most frequent  in people 
suffering from multinodular goiter followed by 
solitary toxic adenomas.18 Our findings also match 
with the results of the most extensively investigated 
outbreak of IIH, in Tasmania in late 1960s following 
iodine supplementation which occurred most 
frequently in individuals over 40 years of age with 
multinodular goitre.20 
    The reason for IIH in patients of multinodular 
goiter, living in long standing iodine deficiency 
conditions seems to be the iodine intake, which is an 
important up or downregulator of the activity of the 
follicular cells of the normal thyroid gland. Changes in 
iodine intake may modify the risk for or modulate 
thyroid diseases. The follicular cells of the thyroid 
often undergo transformation to develop 
monoclonal(benign) nodules or polyclonal multifocal 
nodularity,a process modulated by iodine intake. 
Studies of patients with thyroid disorders have 
demonstrated that the abnormal thyroid gland is often 
unable to handle a sudden iodine load appropriately.21 
In our study the frequency of history of Iodized salt 
use for more than 2 years by patients (n=150) was 
found 68.6%. Similar kind of results were obtained in 
Zaire.22 The introduction of iodized salt in Zimbabwe 
was associated with a sharp increase over 18 months 
in the incidence of IIH, from 2.8 in 100,000 to 7.4 in 
100,000 inhabitants.11 In another study carried out in 
seven countries, it was reported that IIH occurred only 
when the introduction of iodized salt had been of 
recent onset (<2 years).It seems that the risk of IIH 
after correction of iodine deficiency is closely related 
to a recent excessive increment of iodine supply.23 In 
Brazil, Argentina, and Chile, from 1969 to 1989, a 
marked increase in thyrotoxicosis was observed, three 
years after introduction of iodized salt.23-26 These 
diverse findings must be interpreted carefully because 
they are subject to amount of iodized salt imported or 
produced in an affected country. The iodized salt 
quality from the site of production to household level 
is not necessarily accurate. For example, in South 
Africa, only 62.4% of salt at household level was 
adequately iodized (contains more than 15 mg iodine 
per kilogram).27 A study from Germany in borderline 
iodine deficiency region, disclosed iodine 
contamination from various sources in 21.3% of 395 
subjects, who had thyrotoxicosis.8 
     Available evidence clearly confirms that the 
benefits of correcting iodine deficiency far outweigh 
the risks of iodine supplementation.37 Some studies 
regarding Quality Control of iodized salt have already 
been done in our country, but we still need extensive 
salt quality control and monitoring of population 
iodine status to avoid over or under iodization of 
salt.28-30 
     Use of iodized salt for 2 years is found more 
frequent among patients of hyperthyroidism in this 
study. Study also confirms that nodular goiter is the 
most frequent type of goiter found in hilly areas. In 
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our study positive family history of goiter is also more 
common among patients of hyperthyroidism and 
symptom of heat intolerance is the most frequently 
reported symptom. 
Conclusion 
1.Iodine-induced hyperthyroidism and other adverse 
effects can be avoided by adequate and sustained 
quality control and monitoring of iodine 
supplementation.  
2.It is required to identify people at risk of developing 
hyperthyroidism so that indiscriminate use of iodized 
salt can be avoided in these people.  
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